The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release
Hermans, M.A.W., Schrijver, B., van Holten-Neelen, J.C.P.A., Gerth van Wijk, R., van Hagen, P.M., van Daele, P.L.A., Dik, W.A.Language:
english
Journal:
Clinical & Experimental Allergy
DOI:
10.1111/cea.13217
Date:
June, 2018
File:
PDF, 437 KB
english, 2018